Literature DB >> 22622229

Epigenetics of major psychosis: progress, problems and perspectives.

Viviane Labrie1, Shraddha Pai, Arturas Petronis.   

Abstract

Understanding the origins of normal and pathological behavior is one of the most exciting opportunities in contemporary biomedical research. There is increasing evidence that, in addition to DNA sequence and the environment, epigenetic modifications of DNA and histone proteins may contribute to complex phenotypes. Inherited and/or acquired epigenetic factors are partially stable and have regulatory roles in numerous genomic activities, thus making epigenetics a promising research path in etiological studies of psychiatric disease. In this article, we review recent epigenetic studies examining the brain and other tissues, including those from individuals with schizophrenia (SCZ) and bipolar disorder (BPD). We also highlight heuristic aspects of the epigenetic theory of psychiatric disease and discuss the future directions of psychiatric epigenetics.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22622229      PMCID: PMC3422438          DOI: 10.1016/j.tig.2012.04.002

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  103 in total

Review 1.  CNVs: harbingers of a rare variant revolution in psychiatric genetics.

Authors:  Dheeraj Malhotra; Jonathan Sebat
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

2.  Personal genomes: The case of the missing heritability.

Authors:  Brendan Maher
Journal:  Nature       Date:  2008-11-06       Impact factor: 49.962

Review 3.  Small noncoding RNAs in the germline.

Authors:  Jonathan P Saxe; Haifan Lin
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-09-01       Impact factor: 10.005

4.  Methamphetamine use and schizophrenia: a population-based cohort study in California.

Authors:  Russell C Callaghan; James K Cunningham; Peter Allebeck; Tamara Arenovich; Gautam Sajeev; Gary Remington; Isabelle Boileau; Stephen J Kish
Journal:  Am J Psychiatry       Date:  2012-04       Impact factor: 18.112

Review 5.  Schizophrenia: an epigenetic puzzle?

Authors:  A Petronis; A D Paterson; J L Kennedy
Journal:  Schizophr Bull       Date:  1999       Impact factor: 9.306

6.  Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons.

Authors:  Jian Feng; Yu Zhou; Susan L Campbell; Thuc Le; En Li; J David Sweatt; Alcino J Silva; Guoping Fan
Journal:  Nat Neurosci       Date:  2010-03-14       Impact factor: 24.884

7.  Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration.

Authors:  Juan M Alarcón; Gaël Malleret; Khalid Touzani; Svetlana Vronskaya; Shunsuke Ishii; Eric R Kandel; Angel Barco
Journal:  Neuron       Date:  2004-06-24       Impact factor: 17.173

8.  Monozygotic twins exhibit numerous epigenetic differences: clues to twin discordance?

Authors:  Arturas Petronis; Irving I Gottesman; Peixiang Kan; James L Kennedy; Vincenzo S Basile; Andrew D Paterson; Violeta Popendikyte
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

9.  HDAC2 negatively regulates memory formation and synaptic plasticity.

Authors:  Ji-Song Guan; Stephen J Haggarty; Emanuela Giacometti; Jan-Hermen Dannenberg; Nadine Joseph; Jun Gao; Thomas J F Nieland; Ying Zhou; Xinyu Wang; Ralph Mazitschek; James E Bradner; Ronald A DePinho; Rudolf Jaenisch; Li-Huei Tsai
Journal:  Nature       Date:  2009-05-07       Impact factor: 49.962

10.  DNA methylation affects nuclear organization, histone modifications, and linker histone binding but not chromatin compaction.

Authors:  Nick Gilbert; Inga Thomson; Shelagh Boyle; James Allan; Bernard Ramsahoye; Wendy A Bickmore
Journal:  J Cell Biol       Date:  2007-05-07       Impact factor: 10.539

View more
  42 in total

1.  Identification of schizophrenia-associated loci by combining DNA methylation and gene expression data from whole blood.

Authors:  Kristel R van Eijk; Simone de Jong; Eric Strengman; Jacobine E Buizer-Voskamp; René S Kahn; Marco P Boks; Steve Horvath; Roel A Ophoff
Journal:  Eur J Hum Genet       Date:  2014-11-26       Impact factor: 4.246

Review 2.  Epigenetic studies of schizophrenia: progress, predicaments, and promises for the future.

Authors:  Emma Dempster; Joana Viana; Ruth Pidsley; Jonathan Mill
Journal:  Schizophr Bull       Date:  2012-12-04       Impact factor: 9.306

Review 3.  Decoding the non-coding genome: elucidating genetic risk outside the coding genome.

Authors:  C L Barr; V L Misener
Journal:  Genes Brain Behav       Date:  2016-01-04       Impact factor: 3.449

Review 4.  Animal models of gene-environment interaction in schizophrenia: A dimensional perspective.

Authors:  Yavuz Ayhan; Ross McFarland; Mikhail V Pletnikov
Journal:  Prog Neurobiol       Date:  2015-10-25       Impact factor: 11.685

Review 5.  5-Hydroxymethylcytosine: A new player in brain disorders?

Authors:  Ying Cheng; Alison Bernstein; Dahua Chen; Peng Jin
Journal:  Exp Neurol       Date:  2014-05-17       Impact factor: 5.330

6.  The crossroads of psychiatric epigenomics.

Authors:  Arturas Petronis; Viviane Labrie
Journal:  World Psychiatry       Date:  2019-10       Impact factor: 49.548

Review 7.  Ketamine and phencyclidine: the good, the bad and the unexpected.

Authors:  D Lodge; M S Mercier
Journal:  Br J Pharmacol       Date:  2015-07-28       Impact factor: 8.739

Review 8.  S-Nitrosylation in neurogenesis and neuronal development.

Authors:  Shu-ichi Okamoto; Stuart A Lipton
Journal:  Biochim Biophys Acta       Date:  2014-12-18

Review 9.  The epigenome and postnatal environmental influences in psychotic disorders.

Authors:  Ehsan Pishva; Gunter Kenis; Daniel van den Hove; Klaus-Peter Lesch; Marco P M Boks; Jim van Os; Bart P F Rutten
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-02-19       Impact factor: 4.328

Review 10.  Developing epigenetic diagnostics and therapeutics for brain disorders.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Trends Mol Med       Date:  2013-10-18       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.